BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32447627)

  • 1. Computed tomography screening for lung cancer.
    Sudarshan M; Murthy S
    Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):660-664. PubMed ID: 32447627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rationale for, and design of, a lung cancer screening program.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79(5):337-45. PubMed ID: 22550076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
    Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
    Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the Optimum Screening Strategy for the Early Detection of Lung Cancer.
    Baldwin DR; Callister ME
    Clin Oncol (R Coll Radiol); 2016 Nov; 28(11):672-681. PubMed ID: 27544425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
    Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
    J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lung cancer screening with thoracic X‑ray and CT : Current situation].
    von Stackelberg O; Kauczor HU
    Radiologe; 2016 Sep; 56(9):793-7. PubMed ID: 27411917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer screening: the radiologist's perspective.
    Prokop M
    Semin Respir Crit Care Med; 2014 Feb; 35(1):91-8. PubMed ID: 24481763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
    N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.
    Meza R; ten Haaf K; Kong CY; Erdogan A; Black WC; Tammemagi MC; Choi SE; Jeon J; Han SS; Munshi V; van Rosmalen J; Pinsky P; McMahon PM; de Koning HJ; Feuer EJ; Hazelton WD; Plevritis SK
    Cancer; 2014 Jun; 120(11):1713-24. PubMed ID: 24577803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose computed tomography lung cancer screening.
    Furlow B
    Radiol Technol; 2014; 85(3):297CT-314CT; quiz 315CT-318CT. PubMed ID: 24395909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for lung cancer. Too many uncertainties, even for smokers.
    Prescrire Int; 2014 Jan; 23(145):19-23. PubMed ID: 24516909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lung cancer screening among the smoker population].
    Coureau G; Delva F
    Bull Cancer; 2019; 106(7-8):693-702. PubMed ID: 30777302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evidence for low-dose CT screening of lung cancer.
    Ruchalski K; Gutierrez A; Genshaft S; Abtin F; Suh R
    Clin Imaging; 2016; 40(2):288-95. PubMed ID: 26362352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reduction in lung cancer mortality by screening programs in smokers--low dose spiral CT is superior to conventional chest X-ray].
    Weiß M
    Rofo; 2014 Jan; 186(1):14. PubMed ID: 24511605
    [No Abstract]   [Full Text] [Related]  

  • 16. 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.
    Røe OD; Markaki M; Tsamardinos I; Lagani V; Nguyen OTD; Pedersen JH; Saghir Z; Ashraf HG
    BMJ Open Respir Res; 2019; 6(1):e000512. PubMed ID: 31803478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer screening: advantages, controversies, and applications.
    Nanavaty P; Alvarez MS; Alberts WM
    Cancer Control; 2014 Jan; 21(1):9-14. PubMed ID: 24357736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The National Lung Screening Trial Premise of Null and Chest Radiography Equivalence Is Open to Question.
    Reich JM; Kim JS
    AJR Am J Roentgenol; 2015 Aug; 205(2):278-9. PubMed ID: 26204275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.